LifeSADX CoV-2 IgT

Louis Roux

+27 21 788 6989

This SARS-CoV-2 lateral flow assay detects total antibodies (IgA/IgG/IgM) against SARS-CoV-2 in human blood and serum. SARS-CoV-2 antibodies in the specimen bind to SARS-CoV-2 antigen-coated gold nanoparticles (AuNP) forming AuNP-complexes.

Product or Service

HS300220 - Vaccines; for human medicine

Facility

Other

Product Certification

Product or Service Certification

Contact Infomation

Company Name: Lifeassay Diagnostics PTY LTD

Company Address: 7 Bell Crescent, Westlake Business Park, 7945, South Africa

Company General Phone: +27 21 788 6989

Company General Mail: info@lifeassay.com

Company Website: www.lifesadx.com

Key Contact: Louis Roux

Key Contact Phone: +27 83 267 2067

Key Contact General Mail: info@lifeassay.com

Company Information

Incorporation Date: October 01, 2009

BEE: Not BEE Eligible

Woman-Owned: No

Company Size: 10 – 20

Distribution: Other

Company Overview: At LifeSADX we believe that all great companies had small beginnings. Therefore the smallest customer is of great importance to us. We strive to ensure that our response time is the shortest possible, that information supplied is accurate and precise, and that contact with customers remains highly professional at all times. Programmes for ongoing customer satisfaction and customer support take the highest priority and are measured continuously to ensure QUALITY is delivered IN FULL and ON TIME. LifeSADX’s manufacturing facilities are based in Cape Town, South Africa. The Cape Town plant is ISO13485:2016 certified

Year Started Exporting:

2010

Countries Currently Exporting to:

Botswana, Dominican Republic, Egypt, France, Germany, Ghana, Kenya, Lesotho, Malawi, Mozambique, Pakistan, Zimbabwe

Countries Hoping to Export to:

Japan, United States

Registered Under the Following Trade Agreements:

None